Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope
Open Access
Abstract
Starting with the enhanced permeability and retention (EPR) effect discovery, nanomedicine has gained a crucial role in cancer treatment. The advances in the field have led to the approval of nanodrugs with improved safety profile and still inspire the ongoing investigations. However, several restrictions, such as high manufacturing costs, technical challenges, and effectiveness below expectations, raised skeptical opinions within the scientific community about the clinical relevance of nanomedicine. In this review, we aim to give an overall vision of the current hurdles encountered by nanotherapeutics along with their design, development, and translation, and we offer a prospective view on possible strategies to overcome such limitations.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (21565-2018)
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2017E3A2NR-2017)
- Regione Lombardia (Direzione Generale Ricerca, Innovazione, Università, Export e Internazionalizzazione)
This publication has 148 references indexed in Scilit:
- Targeting of Tumor-Associated Macrophages Made Possible by PEG-Sheddable, Mannose-Modified NanoparticlesMolecular Pharmaceutics, 2013
- Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in MicePLOS ONE, 2013
- The big picture on nanomedicine: the state of investigational and approved nanomedicine productsNanomedicine: Nanotechnology, Biology and Medicine, 2013
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumorsProceedings of the National Academy of Sciences, 2012
- Softer Zwitterionic Nanogels for Longer Circulation and Lower Splenic AccumulationACS Nano, 2012
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent mannerNature Nanotechnology, 2012
- Diffusion of Particles in the Extracellular Matrix: The Effect of Repulsive Electrostatic InteractionsBiophysical Journal, 2010
- Gadolinium Chloride Augments Tumor-Specific Imaging of Targeted Quantum Dots In VivoACS Nano, 2010
- Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubblesJournal of Controlled Release, 2009
- Renal clearance of quantum dotsNature Biotechnology, 2007